Home > BRISA > Search result
COVID-19

In this section you will find the HTA reports produced by RedETSA members in response to the COVID-19 pandemic. For additional resources, please visit PAHO’s website.


Limitation of Liability

The information, products, services, tools and/or opinions shared and expressed on the platform are the sole responsibility of the institutions that produce them, and do not necesarily represent the views of PAHO/WHO.

PAHO/WHO and its Specialized Center BIREME make no warranties nor guarantees the accuracy or truthfulness of the information, products, services and/or tools provided. Users must use these products, services and/or tools at their own risk. In no case will PAHO/WHO and its Specialized Center BIREME be liable for damages, even if they may have been warned and/or prevented.

Terms and conditions of use

Results: 3

Informe diário de evidências COVID-19: busca realizada em 29 de julho de 2020

Brasil. Ministério da Saúde. Secretaria de Ciência, Tecnologia, Inovação e Insumos Estratégicos em Saúde.
O Informe Diário de Evidências é uma produção do Ministério da Saúde que tem como objetivo acompanhar diariamente as publicações científicas sobre tratamento farmacológico e vacinas para a COVID-19. Dessa forma, são realizadas buscas estruturadas em bases de dados biomédicas, referentes ao d...
Coronavirus Infections/drug therapy, Pneumonia, Viral/drug therapy, Betacoronavirus/drug effects, Influenza Vaccines/therapeutic use, Chloroquine/therapeutic use, Hydroxychloroquine/therapeutic use, Anti-Inflammatory Agents, Non-Steroidal/therapeutic use, Resveratrol/therapeutic use, Copper/therapeutic use, Interferon alpha-2/therapeutic use, Midazolam/therapeutic use, Ketamine/therapeutic use, Fentanyl/therapeutic use, Propofol/therapeutic use, Immunoglobulins/therapeutic use, Lopinavir/therapeutic use, Ritonavir/therapeutic use, Methylprednisolone/therapeutic use, Azithromycin/therapeutic use, Enoxaparin/therapeutic use, Cohort Studies, Cross-Sectional Studies, Technology Assessment, Biomedical
Fulltext

COVID-19 et les soins palliatifs en contexte de pénuries pendant la pandémie

Institut National d’Excellence en Santé et en Services Sociaux.
CONTEXTE: Le présent document ainsi que les constats qu’il énonce ont été rédigés en réponse à une interpellation du ministère de la Santé et des Services sociaux dans le contexte de l’urgence sanitaire liée à la maladie à coronavirus (COVID-19) au Québec. L’objectif est de réaliser ...
Coronavirus Infections/epidemiology, Palliative Care/organization & administration, Midazolam/therapeutic use, Lorazepam/therapeutic use, Phenobarbital/therapeutic use, Drug Substitution, Technology Assessment, Biomedical, Health Evaluation
Fulltext

Eficacia y seguridad de dexmedetomidina comparado con midazolam y propofol para la sedación leve a moderada de adultos con ventilación mecánica invasiva en unidades de cuidados intensivos

Perú. EsSalud. Instituto de Evaluación de Tecnologías en Salud e Investigación.
INTRODUCCIÓN: El presente dictamen expone la evaluación de la eficacia y seguridad de dexmedetomidina comparado con midazolam y propofol en pacientes adultos en UCI con requerimiento de sedación leve a moderada para destete de la ventilación mecánica invasiva. La sedación es un tratamiento importan...
Dexmedetomidine/therapeutic use, Midazolam/therapeutic use, Respiration, Artificial/instrumentation, Intensive Care Units, Technology Assessment, Biomedical, Cost Efficiency Analysis
Fulltext